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Abstract The lethal toxin of Bacillus anthracis consists of two
proteins, PA and LF, which together induce lethal effects in
animals and cause macrophage lysis. LF is a zinc-endopeptidase
which cleaves two mitogen-activated proten kinase kinases
(MAPKKs), Mek1 and Mek2, within the cytosol. Here, we
show that also MKK3, another dual-specificity kinase that
phosphorylates and activates p38 MAP kinase, is cleaved by LF
in macrophages. No direct correlation between LF-induced cell
death and cleavage of these MAPKKs was found in macrophage
cell lines and primary peritoneal cells exhibiting different
sensitivity to LF. However, we present the first evidence that
sublytic doses of LF cleave Meks and cause a substantial
reduction in the production of NO and tumour necrosis factor-K
induced by lipopolysaccharide/interferonQ. We suggest that this
effect of LF is relevant during the first stages of B. anthracis
infection, when a reduction of the inflammatory response would
permit growth and diffusion of the bacterium.
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1. Introduction
Anthrax is an acute disease of animals and humans caused
by the ingestion or inhalation of spores of pathogenic strains
of Bacillus anthracis. This Gram-positive bacterium produces
two primary virulence factors: poly-D-glutamic acid capsule
and two toxic complexes composed of three distinct proteins:
protective antigen (PA, 83 kDa), oedema factor (EF, 88 kDa)
and lethal factor (LF, 89 kDa) [1]. In laboratory animals,
intradermal injection of a PA-EF mixture induces oedema
which is associated with the adenylate cyclase activity of EF
[2,3]. The intravenous injection of PA and LF (Letx) produces
rapid lethal e¡ects. In vitro, Letx causes death of macro-
phages and macrophage cell lines with a few hours, whereas
all other types of cells tested appear essentially una¡ected,
even though they internalise the toxin [4]. There is a large
variation in the development of anthrax among laboratory
animals, basically due to a di¡erent ability to interfere with
the mechanism of initial germination of spores and the ensu-
ing bacterial multiplication with production of large amounts
of Letx [5^7].
PA binds to an unknown cellular receptor and it is then
cleaved by a furin-like surface protease leading to the expo-
sure of a binding site for EF and LF. Their binding to PA
triggers a receptor-mediated endocytosis which drives LF or
EF inside endosomes [8,9]. There is evidence that LF escapes
from the lumen of endosomal compartments into the cytosol
[10], where it displays its zinc-endoprotease activity and cyto-
toxicity, which is inhibited by some membrane-permeant me-
talloprotease inhibitors [11].
Recently, the mitogen-activated protein kinase kinase
(MAPKK) isoforms Mek1 and Mek2 were identi¢ed as cyto-
solic targets of LF activity using two entirely di¡erent exper-
imental approaches [12,13]. Mek1 and Mek2 are cleaved by
LF at peptide bonds very close to their N-termini. Mek1 and
2 are dual-speci¢city kinases with a key role in cell growth,
proliferation, di¡erentiation and apoptosis [14]. They are key
mediators of signal transduction from the cell surface to the
nucleus. The signalling pathways involving MAPKK1/2
(Mek1 and Mek2) and MAPKK3 (MKK3) play a crucial
role in the activation of macrophages and are directly in-
volved in the production of cytokines, i.e. in the biosynthesis
of tumour necrosis factor-K (TNFK), interleukin (IL)-1 and
IL-6 [15^17]. Cleavage of MAPKKs by Letx in the N-terminal
region is associated with a transient phosphorylation of their
substrates ERK1 and ERK2 [13]. These results established LF
as a novel tool for the study of cell biology processes and as
such it has already been used in probing the role of Meks in
Golgi transport [18]. These ¢ndings also opened the possibility
of linking a de¢ned intracellular biochemical lesion to the
pathogenesis of anthrax, as previously done for many bacte-
rial toxins with intracellular targets [19].
Here, we attempted to correlate the LF cleavage of
MAPKKs to LF toxicity on macrophages by using macro-
phage cell lines sensitive or resistant to LF as well as perito-
neal macrophages isolated from mouse strains with di¡erent
sensitivity to anthrax. We examined a number of macrophage
activities and we found that LF is capable of cleaving MKK3,
an additional MAP kinase kinase isoform. However, no evi-
dence of a direct connection between this N-terminal proteol-
ysis of the MAPKK isoforms 2 and 3 and macrophage cell
death was found. We report here that the release of TNFK
and NO from macrophages is inhibited by LF and suggest
that such inhibition is advantageous to the growth of the
bacterium in the initial phase of infection.
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2. Materials and methods
2.1. Reagents
Interferon-Q (IFNQ), phorbol myristate acetate (PMA) and Esche-
richia coli 026:B6 endotoxin (LPS) were purchased from Sigma Chem-
ical Co.
2.2. Cell cultures
Cells were incubated at 37‡C, 5% CO2 in a humidi¢ed atmosphere.
The murine macrophage cell lines J774.A1 (ATCC TIB 67) and Raw
264.7 (ATCC TIB 71) were obtained from the American Type Culture
Collection and maintained in Dulbecco’s modi¢ed Eagle’s medium
supplemented with heat-inactivated foetal calf serum (FCS) 10%,
10 Wg/ml streptomycin, 10 U/ml penicillin. The MT2 cell line, a
kind gift from Prof. P. Ricciardi-Castagnoli (University of Milan),
is a murine macrophage cell line generated from the thymus of
BALB/cJ strain mice by transformation with a recombinant retrovirus
carrying an avian v-myc oncogene [20]. MT2 cells exhibit responses
typical of primary macrophages when maintained in Iscove medium
5% FCS, 10 Wg/ml streptomycin, 10 U/ml penicillin.
Primary macrophages were isolated from the peritoneum of BALB/
cJ or DBA/2J or A/J mice. Cells were recovered with 5 ml of RPMI
medium, containing FCS 10%, 10 Wg/ml streptomycin, 10 U/ml pen-
icillin. 8U105 peritoneal cells were seeded in four-well Lab-Tek cham-
ber slides (Nunc) 1 day before the experiment. The slides were washed
three times with medium to remove non-adherent cells before treat-
ment with Letx.
2.3. Anthrax lethal factor and cytotoxicity assay
LF was expressed in E. coli strain BL21 and puri¢ed as described
[13]. PA was obtained from the culture supernatant £uids of Bacillus
anthracis strain RP42 (PA LF3 EF3) [21] and was puri¢ed as pre-
viously described [22].
Macrophage cytotoxicity of LF was determined by the method of
Hansen et al. [23] with minor modi¢cations. Brie£y, cells were har-
vested by scraping and plated at a density of 8U104 in 96-well plates
(Falcon, Becton Dickinson), 3.5U105 in four-well plates (Nalgene
Nunc International) or 8U105 in six-well plates (Falcon, Becton Dick-
inson) 1 day before the experiments. After treatment with Letx and/or
other reagents and inhibitors, cells were washed with phosphate-bu¡-
ered saline (PBS), and tetrazolium salt (MTT, 1 mg/ml in PBS) was
added. After 1.5 h incubation, the reaction was stopped by adding the
same volume of 20% sodium dodecyl sulphate (SDS), 50% dimethyl-
formamide, pH 4.7. Plates were shaken overnight at room temper-
ature and absorbance was read at 530 nm in a multiwell plate reader.
2.4. Assay of reactive oxygen indermediates and NO production and
TNFK secretion
Supernatants of Raw 264.7 and MT2 cell cultures, seeded in 96-well
plates and incubated for 14 h with medium or with medium supple-
mented with LPS 10 ng/ml and IFNQ 0.2 U/ml, were assayed for the
presence of TNFK by a speci¢c ELISA test (Genzyme). NO produc-
tion was determined after conversion into nitrites with the Griess
reaction [24].
2.5. MAPKK cleavage
To determine the LF-induced cleavage of Mek2 and MKK3,
3.5U105 MT2 or Raw 264.7 cells were plated in four-well microdishes
(Nalgene Nunc International). The next day, cells were treated with
LF and PA in 0.5 ml of medium. Cells were lysed at di¡erent times
with 100 Wl of Laemmli sample bu¡er containing 5% (v/v) 2-mercap-
toethanol, 10 mM orthophenanthroline and a tablet of inhibitors of
proteases (Complete Mini, Roche Molecular Biochemicals) per 10 ml.
Peritoneal macrophages were treated with the same amount of toxin
for di¡erent times and samples were prepared similarly. All samples
were boiled for 10 min and 10 Wl of each of them was loaded on SDS
10% (w/v) polyacrylamide gels, transferred to Protran nitrocellulose
transfer membranes (Schleicher and Schuell) and probed with a rabbit
polyclonal antibody against Mek2 (N-20, Santa Cruz Biotechnology)
or against MKK3 (C-19, Santa Cruz Biotechnology), both of them
diluted 1:1000. Bound primary antibody was revealed with a horse-
radish peroxidase-conjugated horse anti-rabbit IgG (Calbiochem,
1:2000) and detected by enhanced chemiluminescent substrate Super
Signal West Pico (Pierce). Autoradiographs were analysed by Multi
analyst Gel Doc 2000 (Bio-Rad). At least 105 macrophages have to be
loaded on one lane to detect MAPKK cleavage with variations among
di¡erent experiments within 10%.
3. Results
3.1. MT2 and Raw264.7: two cell lines with di¡erent sensitivity
to Letx as a model to understand the mechanism of action
of LF
Macrophage cell lines di¡er greatly with respect to the cy-
totoxic e¡ect of Letx. No di¡erences in receptor binding, pro-
teolytic activation of PA or LF internalisation were detected
between resistant and sensitive macrophages [9,25]. In prelimi-
nary experiments we found that the MT2 cell line, which ex-
hibits a well de¢ned macrophage phenotype [20], is resistant
to the cytotoxic e¡ect of Letx (Fig. 1). MT2 cells were then
compared to the Raw 264.7 cell line, which is Letx-sensitive
and which is the one most commonly used to study LF cyto-
toxicity [26,27]. Fig. 1 shows that these two cell lines have a
clearly di¡erent response to LF, with MT2 being una¡ected
by 8 h exposure to the toxin, while Raw cells are no longer
Fig. 1. MT2 and Raw 264.7 macrophage cell lines are di¡erentially sensitive to Letx. a: Cells were plated in 96-well plates as described, and
were treated with PA 200 ng/ml at the indicated LF concentrations. After 4 h of incubation, cell death was assayed as described in Section 2.
b: Cells were treated with 200 ng/ml of LF and 200 ng/ml of PA for di¡erent periods of time up to 4 h and then cell death was determined as
in a. Values are expressed as percentage of the control value taken as 100%. The average of three independent experiments performed in dupli-
cate is reported, bars represent S.D.
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viable after 2 h, similar to J774.1 cells, another LF-sensitive
macrophage cell line [10,11,28,29].
3.2. LF cleaves MAPKK isoform 3
It was recently found that Mek1 and Mek2 are cleaved by
LF within their N-termini. Here, using a MKK3-speci¢c anti-
body, we show that MKK3 is also a good substrate of the LF
proteolytic activity (Fig. 2a). Such proteolytic cleavage gener-
ates a MKK3 fragment easily distinguishable from the un-
cleaved form, thus permitting the accurate determination of
the kinetics of cleavage.
Unexpectedly, Mek2 and MKK3 are cleaved with similar
rates in the two cell lines (Fig. 2b). These results do not allow
us to establish a correlation between the isoform of MAPKK
cleaved or the kinetics of the proteolytic reaction and the
di¡erent toxin e¡ect on the two macrophage cell lines.
The opposite fate of Raw264.7 and MT2 exposed to Letx
could be related to a di¡erence in the cascade of events fol-
lowing MAPKK activation. In macrophage cells, MAPKKs
are involved in the cell signalling pathway leading to the re-
lease of cytokines such as TNFK and to other fundamental
activities related to the host defence against bacterial inva-
sions. This possibility was evaluated by comparing
Raw264.7 and MT2 cells for the production of TNFK, sug-
gested to play a central role in the lethal e¡ects of the toxin in
animals [26], and for the production of NO, a central media-
tor of the vascular and in£ammatory response [30] as well as a
microbicidal agent [31]. However, the amount of TNFK and
NO released upon LPS/IFNQ stimulation is comparable in the
two cell lines (Fig. 3).
3.3. Primary cell cultures of peritoneal macrophages with
di¡erent Letx sensitivity show a similar cleavage rate of
Mek2 and MKK3
In order to overcome possible problems related to the use
of macrophage cell lines, which may have altered sets of bio-
chemical activities compared to cells in vivo, peritoneal mac-
rophages were isolated from strains of mice characterised by
di¡erent sensitivities to Letx [5,32]. In particular, A/J and
DBA/2J macrophages are Letx-resistant, whereas BALB/cJ
macrophages are sensitive to LF. Here, the possible correla-
tion between the LF-induced cleavage of MAPKK proteins
Fig. 2. LF cleaves Mek2 and MKK3 with similar rates in sensitive and non-sensitive cells. a: Western blot showing the cleavage of Mek2 and
MKK3 achieved 5 h after the addition of PA (200 ng/ml) plus LF, at the indicated concentrations, to Raw 264.7 and MT2 cells. Cell viability
was identical to controls in samples treated with 4 ng/ml or 10 ng/ml of LF, while it was 50% reduced in the presence of 60 ng/ml of LF. b:
Extent of cleavage as a function of time of Mek2 and MKK3 in macrophage cell lines, determined by densitometric scanning of western blots,
prepared as described in Section 2. Values are expressed as percentage of the control value taken as 100%. Data are the average of three inde-
pendent experiments performed in duplicate and bars represent S.D.
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and cell cytotoxicity should become apparent. The result of
cell viability tests, reported in the inset of Fig. 4a, con¢rms the
di¡erent sensitivity of primary macrophages of A/J, DBA/2J
and BALB/cJ mice, exposed for 4 h to Letx. However, both
Mek2 and MKK3 are cleaved to the same extent and with
very similar kinetics in the macrophages isolated from the
three di¡erent strains (Fig. 4). These data extend the ¢ndings
obtained with macrophage cell lines and reinforce the conclu-
sion that there is no evident direct correlation between LF-
induced cleavage of the MAPKK isoforms considered here
and LF-induced cell cytotoxicity.
3.4. Treatment with sublytic concentration of Letx impairs
activation of macrophages induced by LPS/IFNQ
Impairment of MAPK pathways appears to be an excellent
strategy for pathogenic microbes because it a¡ects the host
in£ammation and immune defence thus creating advantageous
conditions for the survival and multiplication of bacteria [33].
Letx concentration during the pathogenesis of anthrax is low
in the beginning, but increases in parallel with the growth of
the toxin-producing organisms. Therefore, we tested the ef-
fects of sublytic Letx concentrations, such as those present
at the beginning of B. anthracis multiplication, on the cleavage
of MAPKK proteins. We had found (Fig. 2a) that a consis-
tent cleavage of Mek2 and MKK3 takes place at concentra-
tions of LF (4 and 10 ng/ml) which cause no reduction of cell
viability. For comparative reasons, some samples were treated
with 60 ng/ml of LF, a concentration which leads to complete
proteolysis of the MAPKK isoforms tested here (Fig. 2a) with
a concomitant 50% reduction of cell viability (not shown).
Fig. 5 shows that the stimulation of macrophages with LPS/
IFNQ has di¡erent e¡ects on cells pre-treated with Letx and
untreated cells. The production of TNFK and NO is lowered
in cells whose Mek proteins are cleaved, suggesting a role for
LF in the suppression of the release of TNFK and other
proin£ammatory cytokines. It is then possible that B. anthra-
cis can achieve the enormous bacterial proliferation character-
istic of anthrax helped by a preliminary impairment of the
host in£ammatory response.
Fig. 3. LPS/IFNQ-induced production of TNFK and NO by macro-
phage cell lines. Cells were stimulated for 14 h with LPS (10 ng/ml)
and IFNQ (0.2 U/ml). Cell culture media were collected and assayed
for TNFK (a) and NO (b).
Fig. 4. LF-induced cleavage of Meks in peritoneal macrophages. Peritoneal primary macrophages were plated as described in Section 2 and
were treated for the indicated times with 200 ng/ml of LF and 200 ng/ml of PA. The extent of proteolytic cleavage rate of Mek2 (a) and
MKK3 (b) and cell viability (inset), after 4 h, were determined as described in Section 2. Values are the average of two experiments run in du-
plicate and bars represent S.D. values.
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4. Discussion
The MAPK cell activation pathway is involved in a variety
of cellular processes, which include activation of nuclear genes
and of cytosolic activities [14]. Di¡erent isoforms of MAPKK
play a central role in the cascade of phosphorylation events.
LF is a zinc-dependent endopeptidase speci¢c for two
MAPKKs, Mek1 and 2, which are cleaved within their N-
terminus [12,13]. The intravenous injection of PA plus LF
causes the rapid death of animals via haemorrhagic oedema
and macrophages play a key role in the process [26]. The
challenge is now to correlate the biochemical lesion caused
by LF inside cells with the physio-pathological mechanism
leading to animal death. It was shown that PA plus LF causes
the cytolysis of macrophages in culture [4,25^27]. This death
with liberation of pro-in£ammatory cytokines, lysosomal hy-
drolases and other cell necrotic compounds would sustain an
acute in£ammatory reaction. However, we found that MT2
macrophages are resistant to Letx, and that this resistance
cannot be attributed to a lack of cleavage of isoforms 2 and
3 of MAPKKs. In fact, no di¡erence in extent and rate of LF
proteolysis of these MAPKKs could be observed between
Raw264.7 and MT2 macrophages. Thus, an immediate direct
link between the proteolytic cleavage induced by LF in the
cytosol and macrophage cell death is not apparent from these
experiments. Cell lines may deviate from the original pheno-
type and macrophage cell lines are no exception in this re-
spect. However, the lack of correlation is reinforced by the
present ¢ndings that MAPKKs isoforms 2 and 3 are similarly
cleaved by Letx in peritoneal macrophages isolated from the
anthrax-resistant A/J and DBA/2J mice.
The biochemical link between the MAPKK-speci¢c proteo-
lytic activity of LF and macrophage cell death remains to be
established. It was previously found that the LF-induced cy-
tolysis of macrophages requires protein synthesis [34]. Nuclear
transcription and MAPKK-induced activation of cytosolic
phospholipase A2 (PLA2) are not in£uenced by LF, since
LF cytotoxicity in Raw264.7 cells is not a¡ected by the spe-
ci¢c inhibitors K-amanitin and AACOCF3 (our unpublished
results), which block transcription and cytosolic PLA2, respec-
tively.
The major ¢nding described here is of potential relevance in
the ¢rst phase of the development of anthrax, when the num-
ber of bacteria is relatively small and, in parallel, the concen-
tration of circulating Letx is sublytic. In macrophage cell lines
exposed to sublytic concentrations of Letx, MAPKK isoforms
2 and 3 are cleaved with concomitant reduction in the amount
of pro-in£ammatory mediators produced in response to stim-
ulation with LPS/IFNQ. One is tempted to speculate that an
important role of the Letx toxic anthrax complex is that of
reducing the release of pro-in£ammatory mediators from mac-
rophages in the very ¢rst phases of bacterial proliferation,
those which are critical for the determination of the infection
outcome. Among them, the germination of spores inside mac-
rophages appears to be the most important one [7]. If, at this
stage, the amount of Letx produced is su⁄cient to prevent
release of in£ammatory mediators from the infected macro-
phage, this would greatly increase the chances of an ensuing
bacterial proliferation. Later on, the extent of bacterial
growth would reach such dimensions that it can no longer
be controlled by the in£ammatory response, also because
the large amount of released LF would extend its inhibitory
e¡ect to neutrophils [35^36].
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Fig. 5. E¡ect of sublytic doses of anthrax toxic complex on the LPS/IFNQ-induced production of NO and TNFK. Raw 264.7 and MT2 cells
were treated with the indicated amounts of LF together with 200 ng/ml of PA, and then with LPS (10 ng/ml) and IFNQ (0.2 U/ml), and incu-
bated for 14 h before determination of NO (a) and TNFK (b). Undetectable amounts of NO and TNFK were released by untreated cells (not
shown). Values are the average of three di¡erent experiments run in duplicate and bars represent S.D. values.
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